SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030142
Filing Date
2019-08-07
Accepted
2019-08-07 16:38:33
Documents
73
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q myok-10q_20190630.htm   iXBRL 10-Q 2480972
2 EX-31.1 myok-ex311_7.htm EX-31.1 15762
3 EX-31.2 myok-ex312_8.htm EX-31.2 15846
4 EX-32.1 myok-ex321_6.htm EX-32.1 8709
  Complete submission text file 0001564590-19-030142.txt   8285336

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA myok-20190630.xsd EX-101.SCH 55878
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE myok-20190630_cal.xml EX-101.CAL 53562
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE myok-20190630_def.xml EX-101.DEF 158063
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20190630_lab.xml EX-101.LAB 392319
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20190630_pre.xml EX-101.PRE 306472
10 EXTRACTED XBRL INSTANCE DOCUMENT myok-10q_20190630_htm.xml XML 1609741
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37609 | Film No.: 191006032
SIC: 2834 Pharmaceutical Preparations